• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

1 in 3 Primary Care Physicians Have Already Tried AI Scribe Tools

by Syed Hamza Sohail 12/13/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • Elation Health, the clinical-first technology company powering innovation in primary care, today announced the results of a survey of 229 primary care physicians focused on the benefits, desired features, and hurdles to adoption of artificial intelligence–powered (AI) medical scribe tools in the EHR.
  • AI scribe tools use speech recognition and natural language processing to capture and transcribe conversations between a physician and a patient during clinical encounters. 

Survey Outlines Hurdles to Adoption of AI Medical Scribe Tools in Healthcare

The survey indicates that 67% of primary care physicians haven’t experimented with AI scribe solutions and are relying on Electronic Health Record (EHR) vendors for guidance on suitable options compatible with their systems. Among those delaying adoption, concerns include doubts about accuracy, insufficient integration with existing tools, and time constraints for research. 

Independent primary care physicians who haven’t tested AI scribe tools express interest in three main benefits: time savings (93%), improved clinician care experience (higher quality documentation, reduced cognitive burden, and enhanced job satisfaction), and enhanced patient care experience (improved focus on patients and more time for care coordination). Approximately 33% of respondents are currently testing AI scribe technologies, but these early adopters express dissatisfaction with existing solutions, seeking advanced features like better template personalization, patient education materials, and automation of repetitive tasks. Both those trialing and those opting not to purchase are turning to EHR vendors for potential solutions.

“Historically, healthcare technologies have been perceived to reduce physicians’ ability to connect with patients, underdeliver on time-saving promises, and distract them from delivering high-quality care,” said Kyna Fong, Ph.D., co-founder and CEO of Elation Health. “This survey affirms that our clinicians are cautiously optimistic about the potential of AI and its promise. As we continue in our mission to serve primary care physicians with trusted solutions that support high-value patient care, our team is thoughtfully building and applying AI’s powerful capabilities to meaningfully support clinicians that rely on Elation’s modern EHR platform.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Elation Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |